figitumumab (100)(62)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLLESGGG LVQPGGSLRL SCTASGFTFS SYAMNWVRQA PGKGLEWVSA   50

ISGSGGTTFY ADSVKGRFTI SRDNSRTTLY LQMNSLRAED TAVYYCAKDL  100

GWSDSYYYYY GMDVWGQGTT VTVSSASTKG PSVFPLAPCS RSTSESTAAL  150

GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL SSVVTVPSSN  200

FGTQTYTCNV DHKPSNTKVD KTVERKCCVE CPPCPAPPVA GPSVFLFPPK  250

PKDTLMISRT PEVTCVVVDV SHEDPEVQFN WYVDGVEVHN AKTKPREEQF  300

NSTFRVVSVL TVVHQDWLNG KEYKCKVSNK GLPAPIEKTI SKTKGQPREP  350

QVYTLPPSRE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP  400

MLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG  450

Light chain / Chaone lygire / Cadena ligera

DIQMTQFPSS LSASVGDRVT ITCRASQGIR NDLGWYQQKP GKAPKRLIYA   50

ASRLHRGVPS RFSGSGSGTE FTLTISSLQP EDFATYYCLQ HNSYPCSFGQ  100

GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV  150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG  200

LSSPVTKSFN RGEC                                         214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	152-208	265-325	371-429

	22??-96??	152??-208??	265??-325??	371??-429??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	139-214?	139??-214???



Inter-H-H	227-227??	228-228??	231-231??	234-234??



N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

301, 301??

Molecular formula	C6450H9924N1732O2018S54 

Description

immunoglobulin G2-kappa, anti-[Homo sapiens insulin-like growth factor I
receptor (IGF-1R, CD221)], Homo sapiens monoclonal antibody; 

gamma2 heavy chain (1-450) [Homo sapiens VH (IGHV3-23*01 (93.90%)
-(IGHD)-IGHJ6*01) [8.8.18] (1-125) -IGHG2*01, CH3 K130>del (126-450)],
(139-214?)-disulfide with kappa light chain (1?-214?) [Homo sapiens
V-KAPPA (IGKV1-17*01 (95.80%) -IGKJ2*04) [6.3.9] (1?-107?) -IGKC*01]
(108?-214?); (227-227??:228-228??:231-231??:234-234??)-tetradisulfide
dimer 

	

WHO 

International Nonproprietary Names Programme	

9085

December 2008

Page 1/1

		

